Medtronic has recalled more than 204,000 devices used to assist hospital and other patients with end-stage heart failure due to the potential for power source interruptions, the Food and Drug Administration reported Friday. The HeartWare Ventricular Assist Device is used as a bridge to cardiac transplantation in patients who are at risk of death from end-stage left ventricular heart failure. Health care professionals and consumers may report adverse reactions and quality problems with the devices to the FDA’s MedWatch program. For more information, see the recent Medtronic letter to health care providers.

Related News Articles

Headline
The Committee on Ways and Means today convened a hearing examining the disproportionate effect COVID-19 is having on minority communities. “Many communities…
Perspective
In Michigan, African Americans make up 14% of the population … but account for 40% of the COVID-19 deaths. In Chicago: 30% of the population … and 46% of the…
Headline
The Department of Health and Human Services’ Office of Minority Health May 1 announced it will provide funding to help deliver important COVID-19-related…
Headline
Hospitals and health systems continue to provide care for our most vulnerable communities by addressing social needs, educating on COVID-19 risks and…
Headline
A study of 305 hospitalized adult COVID-19 patients in Georgia found an overrepresentation of black patients, with over a quarter lacking known risk factors,…
Blog
The AHA is committed to ensuring that all people, regardless of background or zip code, have equitable access to quality health care. As the COVID-19 pandemic…